SCHEMBL31332525

SCHEMBL31332525

CCOC(=O)c1c(F)c2c(Cl)c(F)ccc2n1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KDM4E B2RXH2 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ NOD2 Q9HC29 4/20 0.47
▸ NOD1 Q9Y239 4/20 0.47
▸ MAPT P10636 1/20 0.43
▸ GAA P10253 1/20 0.41
▸ PTGDR2 Q9Y5Y4 2/20 0.41
▸ PTGDR Q13258 1/20 0.39
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ CYP2C9 P11712 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ PSEN1 P49768 1/20 0.37
▸ PSEN2 P49810 1/20 0.37
▸ APH1B Q8WW43 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31332470 0.85 NOD2 (0.52) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL12228539 0.74 NOD2 (0.44) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL14115908 0.73 NOD2 (0.44) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL12228600 0.73 NOD2 (0.44) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL7467672 0.73 NOD2 (0.50) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL12228599 0.69 NOD2 (0.41) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL7463982 0.69 NOD2 (0.46) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL7475342 0.69 NOD2 (0.46) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL7463987 0.69 NOD2 (0.46) KMT2AMEN1KDM4ELMNATSHR
SCHEMBL27834621 0.69 TSHR (0.52) KMT2AMEN1KDM4ELMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747235-A1 KV1.3 POTASSIUM CHANNEL ANTAGONISTS Muna Therapeutics ApS (DK) 2026-05-27 — — EP disclosed
EP-4747234-A1 KV1.3 POTASSIUM CHANNEL ANTAGONISTS Muna Therapeutics ApS (DK) 2026-05-27 — — EP disclosed
WO-2025017105-A1 KV1.3 POTASSIUM CHANNEL ANTAGONISTS MUNA THERAPEUTICS APS (DK) 2025-01-23 — — WO disclosed
WO-2025017103-A1 KV1.3 POTASSIUM CHANNEL ANTAGONISTS MUNA THERAPEUTICS APS (DK) 2025-01-23 — — WO disclosed
Send feedback